查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514977

疫苗合約製造市場，按疫苗類型、產品類型、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Vaccine Contract Manufacturing Market, By Vaccine Type, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 265 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年疫苗合約製造市場規模為 29.0010 億美元，2024 年至 2032 年複合年成長率為 8.00%。

疫苗合約製造市場-市場動態

疫苗和生物技術行業需求的成長預計將推動市場需求

由於疫苗接種計劃的擴大、傳染患者病率的增加以及對新疫苗來對抗新出現的病原體的需求，全球對疫苗的需求持續成長。這種需求促使製藥公司尋求合約製造合作夥伴，以有效擴大生產規模。疫苗生產通常需要專門的設施、技術和專業知識。擁有成熟疫苗生產能力的合約製造商可以提供有效的解決方案，使製藥公司能夠專注於研究、開發和分銷。因此，研究和技術的進步在市場成長中發揮著至關重要的作用。

疫苗生產受到 FDA 和 EMA 等世界各地衛生當局的嚴格監管。擁有成熟的監管合規專業知識的合約製造商可以加快核准流程並確保遵守品質標準，從而縮短新疫苗的上市時間。許多製藥公司可能面臨內部製造能力的限制。合約製造商提供額外的產能、靈活性和可擴展性，以滿足全球疫苗需求和供應的波動。因此，為了提高製造能力，疫苗合約製造可以隨著需求的變化而補充市場成長。

疫苗合約製造市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.00% 左右的複合年成長率成長

根據疫苗類型細分，由於病毒性疾病的高流行，減毒疫苗預計將在 2023 年顯示最大的市場佔有率。

根據產品類型細分，由於單價疫苗類型較高，預計單一疫苗細分市場將在 2023 年顯示最大市場佔有率。

根據應用細分，由於人類疫苗接種需求不斷成長，人類使用細分是 2023 年的主要應用。

根據最終用戶細分，由於製藥公司在疫苗生產方面不斷進行大量開發，製藥公司細分市場將在 2023 年成為領先的最終用戶。

從地區來看，由於頂級市場參與者的存在，北美是 2023 年的主要收入來源。

疫苗合約製造市場-細分分析：

全球疫苗合約製造市場根據疫苗類型、產品類型、應用、最終用戶和地區進行細分。

根據疫苗類型，市場分為四類：減毒疫苗、去活化疫苗、基於 DNA 的疫苗和基於類毒素的疫苗。減毒疫苗市場佔據主導地位。對病毒感染的高需求正在增加對減毒疫苗的需求。

市場依產品類型分為兩類：單一疫苗和組合疫苗。單一疫苗領域主導市場。預計組合疫苗在預測期內將以最高速度成長。

依應用市場分為兩類：人類使用和獸用。人類使用領域主導市場。人類對疫苗接種的需求不斷成長，以避免病毒和嚴重疾病並對其進行預先免疫，這增加了細分市場的需求。

根據最終用戶，市場分為三類：生物製藥公司、研究實驗室等。生物製藥公司細分市場佔據主導地位，預計在預測期內將保持其高度主導地位。生物製藥公司對疫苗的需求和生產數量不斷增加正在推動市場成長。

疫苗合約製造市場 - 地理洞察

在全球範圍內，疫苗合約製造市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。在生產成本降低、生物製藥行業不斷發展以及醫療基礎設施投資增加的推動下，亞太地區疫苗合約製造正在快速成長。印度和中國等國家正在成為全球疫苗供應鏈的關鍵參與者，在具有成本效益的製造和大規模生產能力方面提供競爭優勢。

疫苗合約製造市場-競爭格局：

疫苗合約製造市場的特徵是少數主要公司之間競爭激烈。主導市場的幾家著名合約製造組織（CMO）包括龍沙（Lonza）、康泰倫特（Catalent）、三星生物製劑（Samsung Biologics）等。不斷成長的需求。公司正在投資先進的生物技術平台和製造技術，以提高疫苗生產效率和產量。

最近的發展：

2023 年 10 月，Vaxcyte 和 Lonza Group 合作進行廣譜肺炎鏈球菌結合疫苗 (PCV) 的全球商業生產。

2023 年 12 月，Ajinomoto Co., Inc. 購買了 All Forge Biologics Holdings, LLC 的股票。該設施的目標是提高生物製品的生產能力。

目錄

第1章：疫苗合約製造市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按疫苗類型分類的疫苗合約製造市場片段
    • 按產品類型分類的疫苗合約製造市場片段
    • 按應用分類的疫苗合約製造市場片段
    • 最終用戶的疫苗合約製造市場片段
    • 按國家/地區分類的疫苗合約製造市場片段
    • 按地區分類的疫苗合約製造市場片段
  • 競爭洞察

第 3 章：疫苗合約製造主要市場趨勢

  • 疫苗合約製造市場促進因素
    • 市場促進因素的影響分析
  • 疫苗合約製造市場限制
    • 市場限制影響分析
  • 疫苗合約製造市場機會
  • 疫苗合約製造市場未來趨勢

第 4 章：疫苗合約製造業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：疫苗合約製造市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：疫苗合約製造市場格局

  • 2023 年疫苗合約製造市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：疫苗合約製造市場 - 按疫苗類型

  • 概述
    • 按疫苗類型分類的細分市場佔有率分析
    • 減弱的
    • 去活化
    • 基於DNA
    • 基於類毒素

第 8 章：疫苗合約製造市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 單一疫苗
    • 聯合疫苗

第 9 章：疫苗合約製造市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 人類使用
    • 獸醫

第 10 章：疫苗合約製造市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 生物製藥公司
    • 研究實驗室
    • 其他

第 11 章：疫苗合約製造市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美疫苗合約製造主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按疫苗類型）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲疫苗合約製造主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按疫苗類型）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區疫苗合約製造主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依疫苗類型）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲疫苗合約製造主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按疫苗類型）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲疫苗合約製造主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按疫苗類型）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 疫苗合約製造業

  • 競爭儀表板
  • 公司簡介
    • Lonza Group
    • Emergent BioSolutions
    • Catalent
    • Vaxcyte
    • Samsung Biologics
    • Pfizer CentreOne
    • WuXi Biologics
    • Boehringer Ingelheim BioXcellence
    • Fujifilm Diosynth Biotechnologies
    • AGC Biologics
    • Rentschler Biopharma
    • Cytovance Biologics
    • Grand River Aseptic Manufacturing
    • KBI Biopharma
    • Vetter Pharma
    • Ajinomoto Co Inc.
    • CMC Biologics
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3083

REPORT HIGHLIGHT

Vaccine Contract Manufacturing Market size was valued at USD 2,900.10 Million in 2023, expanding at a CAGR of 8.00% from 2024 to 2032.

The practice of a pharmaceutical firm (the contract manufacturer) producing vaccines for another corporation, or the client is known as vaccine contract manufacturing. Through this agreement, the customer can create vaccines under their specifications and needs by utilizing the contract manufacturer's manufacturing experience, facilities, and capabilities.

Vaccine Contract Manufacturing Market- Market Dynamics

Rising demand for vaccines and the biotechnology industry are expected to propel market demand

The global demand for vaccines continues to rise due to expanding vaccination programs, increasing the prevalence of infectious diseases, and the need for new vaccines to combat emerging pathogens. This demand drives pharmaceutical companies to seek contract manufacturing partners to scale up production efficiently. Vaccine manufacturing often requires specialized facilities, technologies, and expertise. Contract manufacturers with established capabilities in vaccine production can offer efficient solutions, enabling pharmaceutical companies to focus on research, development, and distribution. Thus, advancement in research and technology is playing a vital role in market growth.

Vaccine manufacturing is highly regulated by health authorities worldwide including FDA, and EMA. Contract manufacturers with established regulatory compliance expertise can expedite the approval process and ensure adherence to quality standards, reducing time to market for new vaccines. Many pharmaceutical companies may face limitations in their internal manufacturing capacities. Contract manufacturers provide additional capacity, flexibility, and scalability to meet fluctuating demand and supply vaccines globally. Therefore, to enhance manufacturing capabilities, vaccine contract manufacturing complements the market growth with changing demands.

Vaccine Contract Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, the attenuated segment was predicted to show maximum market share in the year 2023, owing to the high prevalence of viral illness.

Based on Product Type segmentation, the single vaccine segment was predicted to show maximum market share in the year 2023, owing to high monovalent vaccine types.

Based on Application segmentation, the human use segment was the leading Application in 2023, owing to the rising demand for vaccination among humans.

Based on End User segmentation, pharmaceutical companies' segment was the leading End User in 2023, owing to a high number of ongoing developments in pharma companies for vaccine manufacturing.

On the basis of region, North America was the leading revenue generator in 2023, owing to the presence of top market players.

Vaccine Contract Manufacturing Market- Segmentation Analysis:

The Global Vaccine Contract Manufacturing Market is segmented on the basis of Vaccine Type, Product Type, Application, End User, and Region.

The market is divided into four categories based on Vaccine Type: attenuated, inactivated, DNA-based, and toxoid-based. The attenuated vaccine segment dominates the market. High demand for viral infections is boosting the demand for attenuated vaccines.

The market is divided into two categories based on Product Type: single vaccine and combination vaccine. The single vaccine segment dominates the market. Combination vaccine is anticipated to grow at the highest rate during the forecast period.

The market is divided into two categories based on the Application: human use and veterinary. The human use segment dominates the market. The rising need for vaccination in human beings to avoid and pre-immune against viral & severe diseases is augmenting segment demand.

The market is divided into three categories based on End User: biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Increasing number of vaccines need & manufacturing at biopharma companies is fueling market growth.

Vaccine Contract Manufacturing Market- Geographical Insights

Worldwide, the Vaccine Contract Manufacturing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The Asia-Pacific region is witnessing rapid growth in vaccine contract manufacturing, driven by lower production costs, growing biopharmaceutical industry, and increasing investments in healthcare infrastructure. Countries like India and China are becoming key players in global vaccine supply chains, offering competitive advantages in cost-effective manufacturing and large-scale production capabilities.

Vaccine Contract Manufacturing Market- Competitive Landscape:

The market for Vaccine Contract Manufacturing is characterized by stiff competition among few key companies. Several prominent contract manufacturing organizations (CMOs) dominate the market include Lonza, Catalent, Samsung Biologics, etc. These players in the vaccine contract manufacturing market are continuously expanding their production capacities to meet increasing demand. Companies are investing in advanced biotechnological platforms and manufacturing technologies to improve vaccine production efficiency and yield.

Recent Developments:

In October 2023, Vaxcyte and Lonza Group collaborated for global commercial manufacturing of broad-spectrum Pneumococcal Conjugate Vaccines (PCVs).

In December 2023, Ajinomoto Co., Inc. bought All Forge Biologics Holdings, LLC shares. The facility was targeted to boost production abilities for manufacturing biologics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET KEY PLAYERS

  • Lonza Group
  • Emergent BioSolutions
  • Catalent
  • Vaxcyte
  • Samsung Biologics
  • Pfizer CentreOne
  • WuXi Biologics
  • Boehringer Ingelheim BioXcellence
  • Fujifilm Diosynth Biotechnologies
  • AGC Biologics
  • Rentschler Biopharma
  • Cytovance Biologics
  • Grand River Aseptic Manufacturing
  • KBI Biopharma
  • Vetter Pharma
  • Ajinomoto Co Inc.
  • CMC Biologics
  • Others

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019-2032

  • Attenuated
  • Inactivated
  • DNA-based
  • Toxoid-based

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Single vaccine
  • Combination vaccine

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Human Use
  • Veterinary

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Biopharmaceutical Companies
  • Research Laboratories
  • Others

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Vaccine Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Vaccine Contract Manufacturing Market Snippet by Vaccine Type
    • 2.1.2. Vaccine Contract Manufacturing Market Snippet by Product Type
    • 2.1.3. Vaccine Contract Manufacturing Market Snippet by Application
    • 2.1.4. Vaccine Contract Manufacturing Market Snippet by End User
    • 2.1.5. Vaccine Contract Manufacturing Market Snippet by Country
    • 2.1.6. Vaccine Contract Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Vaccine Contract Manufacturing Key Market Trends

  • 3.1. Vaccine Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Vaccine Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Vaccine Contract Manufacturing Market Opportunities
  • 3.4. Vaccine Contract Manufacturing Market Future Trends

4. Vaccine Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Vaccine Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Vaccine Contract Manufacturing Market Landscape

  • 6.1. Vaccine Contract Manufacturing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Vaccine Contract Manufacturing Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
    • 7.1.2. Attenuated
    • 7.1.3. Inactivated
    • 7.1.4. DNA-based
    • 7.1.5. Toxoid-based

8. Vaccine Contract Manufacturing Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 8.1.2. Single vaccine
    • 8.1.3. Combination vaccine

9. Vaccine Contract Manufacturing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Human Use
    • 9.1.3. Veterinary

10. Vaccine Contract Manufacturing Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Biopharmaceutical Companies
    • 10.1.3. Research Laboratories
    • 10.1.4. Others

11. Vaccine Contract Manufacturing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Vaccine Contract Manufacturing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Vaccine Contract Manufacturing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Vaccine Contract Manufacturing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Vaccine Contract Manufacturing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Vaccine Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Vaccine Contract Manufacturing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Lonza Group
    • 12.2.2. Emergent BioSolutions
    • 12.2.3. Catalent
    • 12.2.4. Vaxcyte
    • 12.2.5. Samsung Biologics
    • 12.2.6. Pfizer CentreOne
    • 12.2.7. WuXi Biologics
    • 12.2.8. Boehringer Ingelheim BioXcellence
    • 12.2.9. Fujifilm Diosynth Biotechnologies
    • 12.2.10. AGC Biologics
    • 12.2.11. Rentschler Biopharma
    • 12.2.12. Cytovance Biologics
    • 12.2.13. Grand River Aseptic Manufacturing
    • 12.2.14. KBI Biopharma
    • 12.2.15. Vetter Pharma
    • 12.2.16. Ajinomoto Co Inc.
    • 12.2.17. CMC Biologics
    • 12.2.18. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Vaccine Contract Manufacturing Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global Vaccine Contract Manufacturing Market, by Vaccine Type 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Vaccine Contract Manufacturing Market, by Product Type 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Vaccine Contract Manufacturing Market, by Application 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Vaccine Contract Manufacturing Market, by End User 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Vaccine Contract Manufacturing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Vaccine Contract Manufacturing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vaccine Type segment market share analysis, 2023 & 2030
  • FIGURE Vaccine Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product Type segment market share analysis, 2023 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Europe Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Asia Pacific Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Latin America Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Middle East and Africa Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE Germany Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE India Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Philippines Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE Brazil Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE Saudi Arabia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)